A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act

Client expense: Not reported · Firm income: $70,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

No bill #: legislation to clarify CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests"

Client expense: Not reported · Firm income: $70,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests"

Client expense: Not reported · Firm income: $70,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE